Cargando…

COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies

Detalles Bibliográficos
Autores principales:	Eyal, Nir, Caplan, Arthur, Plotkin, Stanley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Coronavirus – Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920165/ https://www.ncbi.nlm.nih.gov/pubmed/33905309 http://dx.doi.org/10.1080/21645515.2021.1917240

Ejemplares similares

Laying Down the Groundwork for an International Measurement Infrastructure
por: McGilton, Katherine, et al.
Publicado: (2021)

Laying the groundwork for Cloud: a blueprint for enterprise leaders
por: Preston, Mark
Publicado: (2018)

Addressing an urgent global public health need: Strategies to recover routine vaccination during the COVID-19 pandemic
por: Larson, Anna, et al.
Publicado: (2021)

Supercollider: Groundwork
Publicado: (1990)

The Groundwork of Eugenics
Publicado: (1909)

COVID-19 rise in Bangladesh correlates with increasing detection of B.1.351 variant
por: Saha, Senjuti, et al.
Publicado: (2021)

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
por: Martinez, David R., et al.
Publicado: (2021)

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
por: Martinez, David R., et al.
Publicado: (2021)

LAYING THE GROUNDWORK FOR BECOMING AN AGE-FRIENDLY UNIVERSITY: A MULTI-PHASE STUDY
por: Cannon, Melissa L, et al.
Publicado: (2019)

LOS ANGELES COUNTY BOLD INITIATIVE: LAYING THE GROUNDWORK FOR STRATEGIC PLANNING ON DEMENTIA
por: Kuo, Tony, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351
por: Shen, Xiaoying, et al.
Publicado: (2021)

The SARS-CoV-2 B.1.351 Variant Can Transmit in Rats But Not in Mice
por: Zhang, Cheng, et al.
Publicado: (2022)

Faculty drivers and barriers: laying the groundwork for undergraduate STEM education reform in academic departments
por: Shadle, Susan E., et al.
Publicado: (2017)

Development of Cancer in Patients With Heart Failure: How Systemic Inflammation Can Lay the Groundwork
por: Ausoni, Simonetta, et al.
Publicado: (2020)

Laying the groundwork: Building relationships for public and patient involvement in pre‐clinical paediatric research
por: Costello, Wendy, et al.
Publicado: (2019)

Laying the groundwork to make diversity, equity, and inclusion front and center in clinical and translational research
por: Egede, Leonard E., et al.
Publicado: (2023)

Possible recombination between two variants of concern in a COVID-19 patient
por: He, Yaqing, et al.
Publicado: (2022)

The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus
por: Kim, Yeong Jun, et al.
Publicado: (2021)

Detection of B.1.351 SARS-CoV-2 Variant Strain — Zambia, December 2020
por: Mwenda, Mulenga, et al.
Publicado: (2021)

Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant
por: Shinde, Vivek, et al.
Publicado: (2021)

The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients
por: Ruscheweyh, Ruth, et al.
Publicado: (2022)

Making the Case and Laying the Groundwork for Integrating Age-Friendly Practices Into a University Strategic Plan
por: Cannon, Melissa
Publicado: (2020)

Laying the groundwork for the Biobank of Rare Malignant Neoplasms at the service of the Hellenic Network of Precision Medicine on Cancer
por: Kanakoglou, Dimitrios S., et al.
Publicado: (2022)

Active and healthy ageing in urban environments: laying the groundwork for solution-building through citizen science
por: Wood, Grace E R, et al.
Publicado: (2022)

Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
por: Edara, Venkata Viswanadh, et al.
Publicado: (2021)

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
por: Hoffmann, Markus, et al.
Publicado: (2021)

The Infection and Pathogenicity of SARS-CoV-2 Variant B.1.351 in hACE2 Mice
por: Chen, Qi, et al.
Publicado: (2021)

Linked Clusters of SARS-CoV-2 Variant B.1.351 — Maryland, January–February 2021
por: Feder, Kenneth A., et al.
Publicado: (2021)

Early detection of community acquired of SARS-CoV-2 lineage B.1.351 in Hong Kong
por: Tsang, Alan K.L., et al.
Publicado: (2021)

Infection with the SARS-CoV-2 B.1.351 variant is lethal in aged BALB/c mice
por: Yasui, Fumihiko, et al.
Publicado: (2022)

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
por: Wang, Pengfei, et al.
Publicado: (2021)

Correction: The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients
por: Ruscheweyh, Ruth, et al.
Publicado: (2022)

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine
por: Dayan, Gustavo H., et al.
Publicado: (2023)

Direct RT-qPCR assay for SARS-CoV-2 variants of concern (Alpha, B.1.1.7 and Beta, B.1.351) detection and quantification in wastewater
por: Yaniv, Karin, et al.
Publicado: (2021)

Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?
por: Sritipsukho, Paskorn, et al.
Publicado: (2023)

Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route
por: Pan, Ting, et al.
Publicado: (2021)

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
por: Zhou, Daming, et al.
Publicado: (2021)

Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques
por: Yu, Jingyou, et al.
Publicado: (2021)

Effects of B.1.1.7 and B.1.351 on COVID-19 Dynamics: A Campus Reopening Study
por: Linka, Kevin, et al.
Publicado: (2021)

A groundwork for allostatic neuro-education
por: Gerdes, Lee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tjn84uvre7q2b5rhhvfc3069bj